Catalyst Wire Dossier Catalyst Wire Dossier

COMBOGESIC IV

ACETAMINOPHEN AND IBUPROFEN INJECTION · Hikma Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for COMBOGESIC IV, covering 2023-10-17 to 2024-11-21. Get the full timeline:

Most recent: FDA Approved: COMBOGESIC IV — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

See pricing